Dr. Sooren Karayan, MD

Dr. Karayan practices at Major Medical Management, Inc. in Glendale, California.

Dr. Karayan's NPI, 1841377561, was assigned on November 1, 2006. Dr. Karayan graduated from Tehran University of Medical Sciences School of Medicine in 1971. Dr. Karayan's California license number on file is A31692.

Dr. Karayan's primary practice is Major Medical Management, Inc., at 1510 S Central Ave, Glendale, CA 91204 in Los Angeles County. The practice phone is (818) 242-3668.

Dr. Karayan's primary practice is Major Medical Management, Inc. in Glendale, California. Dr. Karayan is also affiliated with Adventist Health Glendale. Dmand AI also links Dr. Karayan to 1 more hospital, 1 physician office and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Karayan practices, 4 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Karayan's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. Karayan is board certified in orthopaedic surgery by the American Board of Orthopaedic Surgery. Dr. Karayan has a license on file in California.

Dmand AI lists arm, wrist, hand fracture and dislocation, arthritis, broken or dislocated ankle/ or foot, bursitis, carpal tunnel syndrome, chest wall injury, enthesopathy in arms and hand joint or tendon inflammation among the conditions Dr. Karayan treats.

CMS data shows 2,348 Medicare services from Dr. Karayan across 21 procedure codes in 2024, for 569 Medicare patients. Medicare paid $157,132 for them.

CMS counts 569 Medicare patients who saw Dr. Karayan in 2024. The largest group is 65 to 74, with 243 patients. 75% of them have arthritis, and 75% have high blood pressure. 93% are also on Medicaid. Their average risk score is 1.49, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Karayan's median patient age at 68, with 67% women.

In 2024, Dr. Karayan wrote 1,099 Medicare Part D claims for 384 patients. 100% of them were for generic drugs. CMS names the drug for 1,072 of them, across 7 drugs with 11 or more claims each, at $6,543 in total drug cost. In 2023, CMS named 1,032 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Karayan for performance year 2024, reported individually. Dr. Karayan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 33 procedures of knee replacement by Dr. Karayan, more than 67% of the clinicians it reports for that procedure.

Hip replacement: 1 to 10 procedures (CMS shows small counts as a range)

Lower limb (leg) arthroscopy (minimally invasive joint repair): 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 21 general payments to Dr. Karayan from 12 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 67% of the total. Zimmer Biomet Holdings, Inc. paid the most, $5,027.

Dr. Karayan graduated from Tehran University of Medical Sciences School of Medicine in 1971.

Dr. Karayan is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Massachusetts and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.